Modified posterior pelvic exenteration for ovarian cancer

International Journal of Gynecological Cancer

Volumn 19, Issue 5, 2009, Pages 968-973

  Houvenaeghel, Gilles ^a   Gutowski, Martin ^b   Buttarelli, Max ^a   Cuisenier, Jean ^c   Narducci, Fabrice ^d   Dalle, Christian ^e   Ferron, Gwenael ^f   Morice, Phillippe ^g   Meeus, Pierre ^h   Stockle, Eberhart ^h   Bannier, Marie ^a   Lambaudie, Eric ^a   Rouanet, Phillippe ^b   Fraisse, Jean ^c   Leblanc, Eric ^d   Dauplat, Jacques ^e   Querleu, Denis ^f   Martel, Pierre ^f   Castaigne, Damien ^g  

^a INSTITUT PAOLI CALMETTES   (France)

^b CENTRE VAL D AURELLE   (France)

^c CENTRE GEORGES FRANÇOIS LECLERC   (France)

^d CENTRE JEAN PERRIN   (France)

^e INSTITUT CLAUDIUS REGAUD   (France)

^f INSTITUT GUSTAVE ROUSSY   (France)

^g Centre L Berard   (France)

^h Service de Chirurgie Oncologique   (France)

Author keywords

Ovarian cancer; Pelvic exenteration

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL ANASTOMOSIS; CYTOREDUCTIVE SURGERY; FEMALE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; MORBIDITY; OVARY CANCER; OVERALL SURVIVAL; PELVIS EXENTERATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RECTUM; STOMA; SURGICAL MORTALITY; ABDOMINAL SURGERY; ANASTOMOSIS; CLINICAL TRIAL; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; OVARY TUMOR; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; ANASTOMOSIS, SURGICAL; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; OVARIAN NEOPLASMS; PELVIC EXENTERATION; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 69449100238     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181a7f38b     Document Type: Article

References (20)

1. Bristow RE, Tomacruz RS, Armstrong DK, et al. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 2002; 20:1248-1259.
2. Eisenkop SM, Nalick RH, Teng NN. Modified posterior exenteration for ovarian cancer. Obstet Gynecol. 1991; 78:879-885.
3. Spirtos NM, Eisenkop SM, Schlaerth JB, et al. Second-look laparotomy after modified posterior exenteration: patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer. Am J Obstet Gynecol. 2000; 182:1321-1327.
4. Bristow RE, del Carmen MG, Kaufman HS, et al. Radical oophorectomy with primary stapled colorectal anastomosis for resection of locally advanced epithelial ovarian cancer. J Am Coll Surg. 2003; 197: 565-573.
5. Guidozzi F, Ball JH. Extensive primary cytoreductive surgery for advanced epithelial ovarian cancer. Gynecol Oncol. 1994; 53:326-330.
6. Clayton RD, Obermair A, Hammond IG, et al. The western Australian experience of the use of en bloc resection of ovarian cancer with concomitant rectosigmoid colectomy. Gynecol Oncol. 2002; 84:53-57.
7. Scarabelli C, Gallo A, Franceschi S, et al. Primary cytoreductive surgery with rectosigmoid colon resection for patients with advanced epithelial ovarian carcinoma. Cancer. 2000; 88:389-397.
8. Benedetti-Panici P, Maneschi F, Scambia G, et al. The pelvic retroperitoneal approach in the treatment of advanced ovarian carcinoma. Obstet Gynecol. 1996; 87:532-538.
9. Obermair A, Hagenauer S, Tamandl D, et al. Safety and efficacy of low anterior en bloc resection as part of cytoreductive surgery for patients with ovarian cancer. Gynecol Oncol. 2001; 83:115-120.
10. Bridges JE, Leung Y, Hammond IG, et al. En bloc resection of epithelial ovarian tumors with concomitant rectosigmoid colectomy: the KEMH experience. Int J Gynecol Cancer. 1993; 3:199-202.
11. Hertel H, Diebolder H, Herrmann J, et al. Is the decision for colorectal resection justified by histopathologic findings: a prospective study of 100 patients with advanced ovarian cancer. Gynecol Oncol. 2001; 83:481-484.
12. Mourton SM, Temple LK, Abu-Rustum NR, et al. Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer. Gyn Oncol. 2005; 99:608-614.
13. Soper JT, Couchman G, Berchuck A, et al. The role of partial sigmoid colectomy for debulking epithelial ovarian carcinoma. Gynecol Oncol. 1991; 41:239-244.
14. Morice P, Dubernard G, Rey A, et al. Results of interval debulking surgery compared with primary debulking surgery in advanced stage ovarian cancer. J Am Coll Surg. 2003; 197:955-963. (Pubitemid 38199555)
15. Van der burgh ME, Van Lent M, Buyse M, et al. The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer. N Eng J Med. 1995; 332:629-634.
16. Eisenkop SM, Friedman RL, Spirtos NM. The role of secondary cytoreductive in the treatment of patients with recurrent epithelial ovarian carcinoma. Cancer. 2000; 88:144-153.
17. Munkarah A, Levenback C, Wolf JK, et al. Secondary cytoreductive surgery for localized intra-abdominal recurrences in epithelial ovarian cancer. Gynecol Oncol. 2001; 81:237-241.
18. Vaccarello L, Rubin SC, Vlamis V, et al. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response. Gynecol Oncol. 1995; 57:61-65.
19. Sonnendecker EWW, Beale PG. Rectosigmoid resection without colostomy during primary cytoreductive surgery for ovarian carcinoma. Int Surg. 1989; 74:10-12.
20. Mirhashemi R, Averette HE, Estape R, et al. Low colorectal anastomosis after radical pelvic surgery: a risk factor analysis. Am J Obstet Gynecol. 2000; 183:1375-1380.